Novo Holdings A/S bought AVLN
May 1, 2026 · Form 4 insider transaction
Novo Holdings A/S bought 555,555 shares of Avalyn Pharma Inc. at $18.00 per share, a transaction worth $10.00M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
555,555
Price
$18.00
Total value
$10.00M
InsiderNovo Holdings A/S
Role10% owner
CompanyAvalyn Pharma Inc. (AVLN)
SecurityVoting Common Stock
Transaction codeP: Open-market purchase
Transaction dateMay 1, 2026
Filing dateMay 5, 2026
Shares owned after3,883,289
OwnershipDirect
10b5-1 planNo
AmendedNo